Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruicong She

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annals of the American Thoracic Society|May 20, 2023
Identification of Environmental Exposures Associated with Risk of Sarcoidosis in African AmericansAlbert M Levin, Ruicong She, Yalei Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Immune-responsive gene 1: The mitochondrial key to Th17 cell pathogenicity in CNS autoimmunityMohammad Nematullah, Mena Fatma, Guoli Zhou, et al.
Journal of the American Heart Association|May 10, 2018
Race and Beta-Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self-Reported Race and Proportion of African Genetic AncestryJasmine A Luzum, Edward Peterson, Jia Li, et al.
Frontiers in Cardiovascular Medicine|July 24, 2024
Genetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fractionVandana Revathi Venkateswaran, Ruicong She, Hongsheng Gui, et al.
Cell Death & Disease|October 23, 2020
miR-504 modulates the stemness and mesenchymal transition of glioma stem cells and their interaction with microglia via delivery by extracellular vesiclesAriel Bier, Xin Hong, Simona Cazacu, et al.
JACC. Heart Failure|November 4, 2017
Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure PatientsDavid E Lanfear, Joseph J Gibbs, Jia Li, et al.
Genes|November 25, 2023
Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection FractionJasmine A Luzum, Alessandra M Campos-Staffico, Jia Li, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
Circulation. Heart Failure|September 19, 2023
Common Variants on <i>FGD5</i> Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF TrialHongsheng Gui, W H Wilson Tang, Stephan Francke, et al.
Circulation. Heart Failure|October 5, 2020
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart FailureDavid E Lanfear, Jasmine A Luzum, Ruicong She, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of the American Thoracic Society|May 20, 2023
Identification of Environmental Exposures Associated with Risk of Sarcoidosis in African AmericansAlbert M Levin, Ruicong She, Yalei Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2025
Immune-responsive gene 1: The mitochondrial key to Th17 cell pathogenicity in CNS autoimmunityMohammad Nematullah, Mena Fatma, Guoli Zhou, et al.
Journal of the American Heart Association|May 10, 2018
Race and Beta-Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self-Reported Race and Proportion of African Genetic AncestryJasmine A Luzum, Edward Peterson, Jia Li, et al.
Frontiers in Cardiovascular Medicine|July 24, 2024
Genetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fractionVandana Revathi Venkateswaran, Ruicong She, Hongsheng Gui, et al.
Cell Death & Disease|October 23, 2020
miR-504 modulates the stemness and mesenchymal transition of glioma stem cells and their interaction with microglia via delivery by extracellular vesiclesAriel Bier, Xin Hong, Simona Cazacu, et al.
JACC. Heart Failure|November 4, 2017
Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure PatientsDavid E Lanfear, Joseph J Gibbs, Jia Li, et al.
Genes|November 25, 2023
Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection FractionJasmine A Luzum, Alessandra M Campos-Staffico, Jia Li, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
Circulation. Heart Failure|September 19, 2023
Common Variants on <i>FGD5</i> Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF TrialHongsheng Gui, W H Wilson Tang, Stephan Francke, et al.
Circulation. Heart Failure|October 5, 2020
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart FailureDavid E Lanfear, Jasmine A Luzum, Ruicong She, et al.
Pageof 3